{"questions":[{"id":"open_question-e8ea55d0-3b24-4628-bd6f-115a58b34c94","artifact_type":"open_question","title":"Coordinate regulation**: How is activity coupled to other spliceosomal steps?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:49.410820+00:00","updated_at":"2026-04-26T03:29:49.410820+00:00"},{"id":"open_question-47753af0-5f7e-4ef8-a8d2-d45b12c3fb59","artifact_type":"open_question","title":"Substrate recognition**: How does SNRNP200 select specific RNA substrates?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:49.338445+00:00","updated_at":"2026-04-26T03:29:49.338445+00:00"},{"id":"open_question-fa691c78-cdff-4b6e-bf67-eda0b9035d6d","artifact_type":"open_question","title":"Mechanism specificity**: How does SNRNP200 select specific substrates?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:49.146325+00:00","updated_at":"2026-04-26T03:29:49.146325+00:00"},{"id":"open_question-6f8bfbff-f48a-41b3-9c07-106ea65350c6","artifact_type":"open_question","title":"Therapeutic optimization**: What is the optimal dosing and timing?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:43.932262+00:00","updated_at":"2026-04-26T03:29:43.932262+00:00"},{"id":"open_question-83935a2d-d2ba-4334-86e9-c5f593748b2f","artifact_type":"open_question","title":"How does Gemin-6 dysfunction contribute to ALS and AD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:47.633971+00:00","updated_at":"2026-04-26T03:29:47.633971+00:00"},{"id":"open_question-fb1afe84-7261-427d-927d-c513e14cb119","artifact_type":"open_question","title":"What is the precise structural role of Gemin-6 in the SMN complex?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:47.515499+00:00","updated_at":"2026-04-26T03:29:47.515499+00:00"},{"id":"open_question-proteins-snrmp200-protein-8b591e51","artifact_type":"open_question","title":"Disease specificity","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-hdac7-59c205f9","artifact_type":"open_question","title":"Gene Therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-gnas-protein-1f3ac1cd","artifact_type":"open_question","title":"Cell-type selective targeting","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn3-protein-f61209c5","artifact_type":"open_question","title":"Structural studies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn3-protein-af3cbb7f","artifact_type":"open_question","title":"Therapeutic development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-nfe2l1-be19d04f","artifact_type":"open_question","title":"Biomarker Development:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-csf2rb-40587849","artifact_type":"open_question","title":"Cell-type resolution","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-epas1-protein-364c60e6","artifact_type":"open_question","title":"Mechanistic Understanding","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-bd718dc4-cc36-4ef5-9cb4-5022f562eee1","artifact_type":"open_question","title":"Therapeutic timing**: At what disease stage would TNN-targeted interventions be most effective?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:57.072361+00:00","updated_at":"2026-04-26T03:26:57.072361+00:00"},{"id":"open_question-9fd4c233-c3b9-4d10-b622-cc4e2f9a3498","artifact_type":"open_question","title":"What is the full extent of DLGAP3's role in neurodegenerative diseases?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:58.153011+00:00","updated_at":"2026-04-26T03:26:58.153011+00:00"},{"id":"open_question-3d32186c-bc56-400a-b326-39c4ce99e3af","artifact_type":"open_question","title":"Can oxidized KCNB1 burden be tracked in accessible biofluids as a progression biomarker?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:17.916501+00:00","updated_at":"2026-04-26T03:29:17.916501+00:00"},{"id":"open_question-c53d88d2-86bc-47ed-8844-0d33502faba3","artifact_type":"open_question","title":"Can deeper biophysical subclassification improve trial design for rare channelopathies?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:55.668921+00:00","updated_at":"2026-04-26T03:28:55.668921+00:00"},{"id":"open_question-672bbec7-02d4-4e5d-9d69-f2a63a658cd7","artifact_type":"open_question","title":"What is the precise molecular mechanism of RAB3B in different vesicle pool regulations?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:52.589119+00:00","updated_at":"2026-04-26T03:27:52.589119+00:00"},{"id":"open_question-052220be-dbb8-4f7c-ac76-4e7c6dc0b367","artifact_type":"open_question","title":"Mechanistic details**: How exactly does GTP hydrolysis drive scission?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:54.676199+00:00","updated_at":"2026-04-26T03:25:54.676199+00:00"},{"id":"open_question-9154d956-9090-4f49-8ab8-972ce7af428f","artifact_type":"open_question","title":"Therapeutic targeting**: How can we specifically modulate dynamin-1?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:54.806990+00:00","updated_at":"2026-04-26T03:25:54.806990+00:00"},{"id":"open_question-fca70b29-968b-4bf8-a816-7ad94bb658b9","artifact_type":"open_question","title":"Can patient-derived iPSC models define responder subgroups for Kv4/KChIP-modulatory therapies?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:03.011994+00:00","updated_at":"2026-04-26T03:27:03.011994+00:00"},{"id":"open_question-2de4e441-d047-4e8b-887a-ae1a831983b5","artifact_type":"open_question","title":"What are the optimal biomarkers for patient selection and response monitoring?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:59.046020+00:00","updated_at":"2026-04-26T03:28:59.046020+00:00"},{"id":"open_question-99da0d41-f7bc-4e00-a3fc-97b824b54b19","artifact_type":"open_question","title":"Therapeutic Window**: What is the optimal level of HDAC7 modulation for neuroprotection?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:00.043173+00:00","updated_at":"2026-04-26T03:29:00.043173+00:00"},{"id":"open_question-proteins-sptlc1-spt-84bf0504","artifact_type":"open_question","title":"Small molecule inhibitors","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-45f3280e-857b-474b-9097-ffc63710c733","artifact_type":"open_question","title":"How does CCM2 dysfunction interact with environmental factors?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:00.437282+00:00","updated_at":"2026-04-26T03:28:00.437282+00:00"},{"id":"open_question-63f86a64-998e-488c-a141-2b484e58b12e","artifact_type":"open_question","title":"Why are dopaminergic neurons selectively vulnerable to TMEM230 dysfunction?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:28.924076+00:00","updated_at":"2026-04-26T03:26:28.924076+00:00"},{"id":"open_question-f7ac248c-e372-4eb1-a2e1-2cf2f0452af6","artifact_type":"open_question","title":"Does NLRC5 expression change in AD or PD brain tissue?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:41.535519+00:00","updated_at":"2026-04-26T03:28:41.535519+00:00"},{"id":"open_question-c397a2a7-f8e0-452b-94c5-ee502403ee54","artifact_type":"open_question","title":"Can NLRC5 modulation affect neuroinflammation in model systems?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:41.595086+00:00","updated_at":"2026-04-26T03:28:41.595086+00:00"},{"id":"open_question-442ca834-cf89-4164-b4e8-465c2d62ed95","artifact_type":"open_question","title":"How does NLRC5 interact with other NLR proteins in brain cells?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:41.652631+00:00","updated_at":"2026-04-26T03:28:41.652631+00:00"},{"id":"open_question-4287115a-0d3a-4729-8e24-4ebc997043b5","artifact_type":"open_question","title":"Combination therapies**: What therapeutic combinations will prove most effective?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:50.257313+00:00","updated_at":"2026-04-26T03:29:50.257313+00:00"},{"id":"open_question-da2a8605-5290-4ee7-b5a6-beabb02d59b4","artifact_type":"open_question","title":"Disease modification**: Can interventions begun early in disease course prevent progression?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:50.365719+00:00","updated_at":"2026-04-26T03:29:50.365719+00:00"},{"id":"open_question-37c838a6-feda-46fd-b415-39d723f13170","artifact_type":"open_question","title":"Biomarker development**: Can we identify robust biomarkers for patient stratification and treatment response?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:50.168702+00:00","updated_at":"2026-04-26T03:29:50.168702+00:00"},{"id":"open_question-c240fc27-52a4-4793-baf1-9b524bc3422d","artifact_type":"open_question","title":"Therapeutic window**: What level of protein reduction would be therapeutic without causing unacceptable side effects?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:50.111428+00:00","updated_at":"2026-04-26T03:29:50.111428+00:00"},{"id":"open_question-7fd5ee69-e773-419f-ba43-157813813f76","artifact_type":"open_question","title":"Mechanism of mutation pathogenesis**: How do specific mutations impair UBQLN2 function, and do they also confer toxic gain-of-function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:50.050808+00:00","updated_at":"2026-04-26T03:29:50.050808+00:00"},{"id":"open_question-014f8f74-5aee-49c4-a093-db046298157d","artifact_type":"open_question","title":"Therapeutic windows**: What is the therapeutic index of spliceosome modulators?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:49.274520+00:00","updated_at":"2026-04-26T03:29:49.274520+00:00"},{"id":"open_question-60c8e45a-0f9f-4e5a-bed2-e059da9ef8f6","artifact_type":"open_question","title":"Cell type vulnerability**: Why are certain neurons more susceptible?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:49.203458+00:00","updated_at":"2026-04-26T03:29:49.203458+00:00"},{"id":"open_question-ba40f4fe-af4b-4644-8e7d-cf21ccf87e9a","artifact_type":"open_question","title":"Combination approaches**: What other therapies synergize with GM-CSF modulation?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:43.988868+00:00","updated_at":"2026-04-26T03:29:43.988868+00:00"},{"id":"open_question-e178fc3c-6752-4195-ba94-01a349fc382c","artifact_type":"open_question","title":"Temporal dynamics**: How does signaling change across disease stages?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:43.874856+00:00","updated_at":"2026-04-26T03:29:43.874856+00:00"},{"id":"open_question-5109874f-7eb8-415b-b690-fa2bb2419a62","artifact_type":"open_question","title":"Can the Gemin-6/7/8 subcomplex be directly targeted for therapeutic benefit?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:47.574445+00:00","updated_at":"2026-04-26T03:29:47.574445+00:00"},{"id":"open_question-proteins-snrmp200-protein-43d0d8b6","artifact_type":"open_question","title":"Substrate recognition","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-snrmp200-protein-1b0c8ce9","artifact_type":"open_question","title":"Coordinate regulation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-snrmp200-protein-fbaa5549","artifact_type":"open_question","title":"Small molecule modulators","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-rbm25-protein-0b2c0c28","artifact_type":"open_question","title":"Therapeutic target","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-d9fd06e2-d61d-4d1b-b16d-aab2ab6c9841","artifact_type":"open_question","title":"Patient selection**: Which patients would benefit from RBM25-targeted therapy?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:36.537033+00:00","updated_at":"2026-04-26T03:29:36.537033+00:00"},{"id":"open_question-d3d4aed0-ad3e-46f4-8742-b78ca0bd965c","artifact_type":"open_question","title":"Therapeutic target**: Is RBM25 a good drug target?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:36.480447+00:00","updated_at":"2026-04-26T03:29:36.480447+00:00"},{"id":"open_question-0532d0f1-cc6a-4a91-8e45-0c36ca3e5e8a","artifact_type":"open_question","title":"Regulation**: What controls RBM25 activity and localization?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:36.308895+00:00","updated_at":"2026-04-26T03:29:36.308895+00:00"},{"id":"open_question-65322dfa-f0c2-4c2a-93e6-543c6ddb07e8","artifact_type":"open_question","title":"Mechanism**: How does RBM25 achieve specificity for different targets?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:36.250520+00:00","updated_at":"2026-04-26T03:29:36.250520+00:00"},{"id":"open_question-a0efcd29-5502-4aa2-b1e4-204d79d8f405","artifact_type":"open_question","title":"Can UPS enhancement rescue established pathology?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:34.545474+00:00","updated_at":"2026-04-26T03:29:34.545474+00:00"},{"id":"open_question-2a4b96e6-3b70-4cf7-b93f-7b0582a2327c","artifact_type":"open_question","title":"How does aging affect the ubiquitin system?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:34.484624+00:00","updated_at":"2026-04-26T03:29:34.484624+00:00"},{"id":"open_question-0934f06c-8438-4668-86d7-a51eb40b0c34","artifact_type":"open_question","title":"What determines whether aggregates are cleared by UPS vs. autophagy?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:34.421817+00:00","updated_at":"2026-04-26T03:29:34.421817+00:00"},{"id":"open_question-fe3a6716-826c-4200-b158-ae50b41ead54","artifact_type":"open_question","title":"How does FIG4 deficiency cause specific neuronal vulnerability?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:28.906268+00:00","updated_at":"2026-04-26T03:29:28.906268+00:00"},{"id":"open_question-20dc5b06-50bc-4843-bcbd-54ae621552c9","artifact_type":"open_question","title":"Can partial UPS enhancement be safely achieved in vivo?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:34.355040+00:00","updated_at":"2026-04-26T03:29:34.355040+00:00"},{"id":"open_question-91caf47c-4f2c-4fc0-af34-053c8690f5c0","artifact_type":"open_question","title":"Therapeutic window**: Can sufficient CNS penetration be achieved without immune suppression?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:26.740898+00:00","updated_at":"2026-04-26T03:29:26.740898+00:00"},{"id":"open_question-96705868-2880-44e9-a6ca-767cd2f7438f","artifact_type":"open_question","title":"Cell-type specificity**: What are the cell-type-specific contributions of CTSL to neurodegeneration?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:26.594610+00:00","updated_at":"2026-04-26T03:29:26.594610+00:00"},{"id":"open_question-1d284e75-1019-4ecd-b4ff-fd58b2a44a03","artifact_type":"open_question","title":"What is the relative contribution of NFE2L1 vs. Nrf2 in neurodegeneration?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:25.699640+00:00","updated_at":"2026-04-26T03:29:25.699640+00:00"},{"id":"open_question-b43a1eec-dcae-4b7e-85a6-99d2641800cb","artifact_type":"open_question","title":"Physiological functions**: What are the normal physiological roles of PEN2 beyond gamma-secretase?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:19.765768+00:00","updated_at":"2026-04-26T03:29:19.765768+00:00"},{"id":"open_question-a5cb0c60-93db-4f5e-aec9-f42be917fb92","artifact_type":"open_question","title":"Can cardiac channelopathy functional pipelines be adapted to CNS sodium-channel targets?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:19.662093+00:00","updated_at":"2026-04-26T03:29:19.662093+00:00"},{"id":"open_question-b7c5a11b-2a57-4d74-8839-0bf1e83db316","artifact_type":"open_question","title":"How should SCN5A variants be stratified for prospective mechanism-matched therapy?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:19.533180+00:00","updated_at":"2026-04-26T03:29:19.533180+00:00"},{"id":"open_question-172bbc99-673c-4ca3-b712-4ceaf2eaeb77","artifact_type":"open_question","title":"Why are neurons specifically vulnerable to UPS dysfunction?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:34.295544+00:00","updated_at":"2026-04-26T03:29:34.295544+00:00"},{"id":"open_question-proteins-stmn1-6737ef5a","artifact_type":"open_question","title":"Personalized medicine","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-e8f325f7-3369-4608-b6e0-3de159a0e997","artifact_type":"open_question","title":"What is the optimal balance between Nrf2 activation and cellular homeostasis?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:32.364096+00:00","updated_at":"2026-04-26T03:29:32.364096+00:00"},{"id":"open_question-d4b94130-56fe-47b7-a25d-80a628a74edf","artifact_type":"open_question","title":"Why does the pathway become unresponsive in chronic neurodegenerative conditions?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:32.285858+00:00","updated_at":"2026-04-26T03:29:32.285858+00:00"},{"id":"open_question-proteins-caml-protein-af9e1da6","artifact_type":"open_question","title":"Structural Studies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-caml-protein-59c205f9","artifact_type":"open_question","title":"Gene Therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dlg5-protein-546e5d1f","artifact_type":"open_question","title":"Therapeutic Development:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-hdac7-994df6e5","artifact_type":"open_question","title":"Epigenetic Editing","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-gnas-protein-24c5bcee","artifact_type":"open_question","title":"Biomarker development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-gnas-protein-adb20a00","artifact_type":"open_question","title":"Combination approaches","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-mekk2-49402d63","artifact_type":"open_question","title":"Combination therapies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-p-tau217-protein-6344a63a","artifact_type":"open_question","title":"Microfluidics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-0451bde5-ed92-47ff-a8d8-d0814bdb998e","artifact_type":"open_question","title":"Can spliceosome function be safely modulated therapeutically?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:49.079938+00:00","updated_at":"2026-04-26T03:25:49.079938+00:00"},{"id":"open_question-2d19c9f2-a702-421f-82f8-bdd947eebea7","artifact_type":"open_question","title":"What is the full extent of PRPF6's substrate specificity?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:49.383770+00:00","updated_at":"2026-04-26T03:25:49.383770+00:00"},{"id":"open_question-abd69f66-3047-45a4-b1f8-a35714975696","artifact_type":"open_question","title":"Are there compensatory mechanisms that could be exploited?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:49.617856+00:00","updated_at":"2026-04-26T03:25:49.617856+00:00"},{"id":"open_question-proteins-stmn1-af3cbb7f","artifact_type":"open_question","title":"Therapeutic development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-vps35-protein-fad976a0","artifact_type":"open_question","title":"Structure-Function Studies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-snrmp200-protein-86eb4155","artifact_type":"open_question","title":"Mechanism specificity","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-vps35-protein-f9c8f85d","artifact_type":"open_question","title":"Biomarker Development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-snrmp200-protein-8f656a56","artifact_type":"open_question","title":"RNA-based therapeutics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-snrmp200-protein-88d0ca18","artifact_type":"open_question","title":"Gene therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-snrmp200-protein-2bea23bb","artifact_type":"open_question","title":"Cell type vulnerability","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-snrmp200-protein-de764e13","artifact_type":"open_question","title":"Therapeutic windows","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-vps35-protein-ff0ab7a0","artifact_type":"open_question","title":"Therapeutic Translation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-rbm25-protein-bf1df157","artifact_type":"open_question","title":"Small molecules","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-rbm25-protein-88d0ca18","artifact_type":"open_question","title":"Gene therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-rbm25-protein-567dca16","artifact_type":"open_question","title":"Patient selection","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn1-protein-fc1c3c3b","artifact_type":"open_question","title":"Single-cell approaches","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn1-protein-e3ccc829","artifact_type":"open_question","title":"Spatial transcriptomics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn1-protein-88d0ca18","artifact_type":"open_question","title":"Gene therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn1-protein-2f1bff4a","artifact_type":"open_question","title":"Protein engineering","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn1-protein-adb20a00","artifact_type":"open_question","title":"Combination approaches","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn1-protein-514f5a79","artifact_type":"open_question","title":"Fluid biomarkers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn1-protein-8ebc8163","artifact_type":"open_question","title":"Imaging biomarkers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-dctn1-protein-ac05c62b","artifact_type":"open_question","title":"Functional biomarkers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-stmn1-49402d63","artifact_type":"open_question","title":"Combination therapies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-pen2-25cab03a","artifact_type":"open_question","title":"Physiological functions","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-pen2-ea02cea4","artifact_type":"open_question","title":"Allosteric vs. orthosteric","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-pen2-25a423e9","artifact_type":"open_question","title":"Cell-type specificity","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-proteins-keap1-protein-bf0362bd","artifact_type":"open_question","title":"Gene therapy:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-69bb5269-d19e-4325-b115-750702b93f3c","artifact_type":"open_question","title":"Disease specificity**: Why do certain mutations cause retina-specific disease?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:49.506454+00:00","updated_at":"2026-04-26T03:29:49.506454+00:00"}],"total":474,"limit":100,"offset":0,"returned":100,"sort":"importance_elo","field":"proteins"}